Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.49 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.48 |
| ▸ | BACE1 | P56817 | 3/20 | 0.48 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.48 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.48 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.47 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.47 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.46 |
| ▸ | GLP1R | P43220 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30784853 | 0.88 | BACE1 (0.56) | F2BACE1BACE2VIPR2NTSR2 | |
| SCHEMBL29462368 | 0.87 | VIPR2 (0.50) | F2VIPR1BACE1BACE2VIPR2 | |
| SCHEMBL29425538 | 0.87 | VIPR2 (0.51) | F2VIPR1BACE1BACE2VIPR2 | |
| SCHEMBL29466598 | 0.86 | VIPR2 (0.54) | F2VIPR1BACE1BACE2VIPR2 | |
| SCHEMBL30883223 | 0.86 | GLP1R (0.62) | VIPR1BACE1GLP1R | |
| SCHEMBL30512765 | 0.85 | BACE1 (0.59) | BACE1BACE2VIPR2 | |
| SCHEMBL30362779 | 0.85 | VIPR2 (0.53) | F2VIPR1BACE1BACE2VIPR2 | |
| SCHEMBL30445824 | 0.85 | NTSR2 (0.56) | F2BACE1BACE2NTSR2NTSR1 | |
| SCHEMBL30512499 | 0.85 | F2 (0.51) | F2NTSR2NTSR1IL23R | |
| SCHEMBL29523711 | 0.84 | BACE1 (0.56) | BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023004424-A2 | GENETICALLY ENGINEERED MULTIFUNCTIONAL EXOSOMES FOR IMMUNOTHERAPY | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-01-26 | — | — | WO | disclosed |